Efforts To Reform Indirect Costs Accounting Spawn Fear That Research Funds May Shrink

While Dingell panel moves to curb misuse of grant money, some observers worry that overall federal support will be reduced WASHINGTON--As Stanford University stands accused of misusing millions of dollars in federal funds meant to reimburse the school for the cost of supporting faculty research, the issue is not simply one of $7,000 bedsheets and $1,200 antique fruitwood commodes. The more important question for scientists is whether some of that money has been diverted from research. Many

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

WASHINGTON--As Stanford University stands accused of misusing millions of dollars in federal funds meant to reimburse the school for the cost of supporting faculty research, the issue is not simply one of $7,000 bedsheets and $1,200 antique fruitwood commodes. The more important question for scientists is whether some of that money has been diverted from research.

Many working scientists, who have long resented what they see as a "tax" collected by the university on their research grants, believe that the answer is yes. They are joined by Rep. John Dingell (D-Mich.) and other members of the oversight subcommittee of the Committee on Energy and Commerce, which conducted a seven-hour hearing last month on the accounting practices of Stanford and the relevant government agencies.

At the same time, federal officials who follow this rather arcane issue say that the money is absolutely necessary for the continued health of the research enterprise. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies